Alturas Analytics
Jenny Willis is a seasoned technical writer with extensive experience in various roles related to health information management and technical documentation. Currently serving as a Technical Writer at Alturas Analytics, Inc., since June 2022, Jenny has also contributed to Just Writing since 2011. Previous positions include HIM Specialist at Surgical Care Affiliates and HIM Specialist III at Columbia Memorial Hospital. In addition, Jenny has held roles at Saint Alphonsus as a Data Integrity Analyst and Patient Service Representative, and as a Laboratory Assistant at Blue Mountain Hospital. Prior to these roles, Jenny was an R&D Project Manager and Quality Engineer/Technical Writer at Boule Medical AB. Jenny holds a Bachelor of Arts in Biology from Swarthmore College and an Associate of Science in Animal Sciences from Bel-Rea Institute of Animal Technology.
This person is not in any teams
Alturas Analytics
At Alturas Analytics, we deliver results on time with the highest level of integrity. Our business is built on developing long term collaborations with our clients by providing advanced MS/MS solutions through a focused emphasis on teamwork, communication and exceptional science. Alturas has a proven record with complex analysis supporting drug candidates for the pharmaceutical and biotechnology industries, from discovery through phase IV clinical trials. The company operates in a GLP environment using validated operational processes in strict adherence to internal SOPs and applicable global regulations. Bioanalytical services routinely performed include the following: • GC-MS/MS and LC-MS/MS bioanalysis – allows for the broadest range of chemical properties across a wide mass range • GLP and non-GLP bioanalysis of large and small molecules in any matrix • Quantitative Antibody Drug Conjugates (ADC) analysis • Biomarker quantitation • Protein binding estimations • Dried Blood (DBS) and Matrix Spot (DMS) analysis (limited sample volume ex. pediatrics, CSF, tears) Ensuring that a project is completed on time to a company's specifications demands clear lines of communication before, during, and after a study's completion. Clients have direct access to a team of professionals who understand the critical nature of the business. An Alturas Study Director is assigned to each client based on their working knowledge with compounds of similar chemical properties. Comments & Feedback: "Thanks. We owe a lot to Alturas for the great nonclinical and clinical bioanalytical support for the program. Happy 2013!" January 2013: Comment from a Sponsor after receiving FDA Approval. “You solved all of our bioanalytical problems.” Comment from a Sponsor after the Alturas Team was able to address technical difficulties. "Five Stars. Would definitely use Alturas again for upcoming projects." Comment from a Sponsor in 2016.